BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 22197448)

  • 1. Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease.
    Wancket LM; Frazier WJ; Liu Y
    Life Sci; 2012 Feb; 90(7-8):237-48. PubMed ID: 22197448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-activated protein kinase phosphatase-1: a critical phosphatase manipulating mitogen-activated protein kinase signaling in cardiovascular disease (review).
    Li CY; Yang LC; Guo K; Wang YP; Li YG
    Int J Mol Med; 2015 Apr; 35(4):1095-102. PubMed ID: 25695424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions.
    Lawan A; Shi H; Gatzke F; Bennett AM
    Cell Mol Life Sci; 2013 Jan; 70(2):223-37. PubMed ID: 22695679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-specificity MAP kinase phosphatases as targets of cancer treatment.
    Nunes-Xavier C; Romá-Mateo C; Ríos P; Tárrega C; Cejudo-Marín R; Tabernero L; Pulido R
    Anticancer Agents Med Chem; 2011 Jan; 11(1):109-32. PubMed ID: 21288197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen activated protein kinase phosphatases and cancer.
    Haagenson KK; Wu GS
    Cancer Biol Ther; 2010 Mar; 9(5):337-40. PubMed ID: 20139719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs.
    Tanoue T; Yamamoto T; Maeda R; Nishida E
    J Biol Chem; 2001 Jul; 276(28):26629-39. PubMed ID: 11359773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cannabinoid receptor type 2 agonist reduces mechanical allodynia and induces mitogen-activated protein kinase phosphatases in a rat model of neuropathic pain.
    Landry RP; Martinez E; DeLeo JA; Romero-Sandoval EA
    J Pain; 2012 Sep; 13(9):836-48. PubMed ID: 22901764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MKP-7, a novel mitogen-activated protein kinase phosphatase, functions as a shuttle protein.
    Masuda K; Shima H; Watanabe M; Kikuchi K
    J Biol Chem; 2001 Oct; 276(42):39002-11. PubMed ID: 11489891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting mitogen-activated protein kinase phosphatase-1 (MKP-1): structure-based design of MKP-1 inhibitors and upregulators.
    Doddareddy MR; Rawling T; Ammit AJ
    Curr Med Chem; 2012; 19(2):163-73. PubMed ID: 22320295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-specificity phosphatases: critical regulators with diverse cellular targets.
    Patterson KI; Brummer T; O'Brien PM; Daly RJ
    Biochem J; 2009 Mar; 418(3):475-89. PubMed ID: 19228121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase phosphatase 1 as an inflammatory factor and drug target.
    Korhonen R; Moilanen E
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):24-36. PubMed ID: 24112275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
    Bardwell AJ; Abdollahi M; Bardwell L
    Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
    Reffas S; Schlegel W
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mitogen-activated protein kinase phosphatase 1, a negative regulator of the mitogen-activated protein kinases, in rheumatoid arthritis: up-regulation by interleukin-1beta and glucocorticoids.
    Toh ML; Yang Y; Leech M; Santos L; Morand EF
    Arthritis Rheum; 2004 Oct; 50(10):3118-28. PubMed ID: 15476200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs).
    Kidger AM; Keyse SM
    Semin Cell Dev Biol; 2016 Feb; 50():125-32. PubMed ID: 26791049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying the regulation of MAP Kinase by MAP Kinase phosphatases in vitro and in cell systems.
    Tárrega C; Nunes-Xavier C; Cejudo-Marín R; Martín-Pérez J; Pulido R
    Methods Mol Biol; 2010; 661():305-21. PubMed ID: 20811991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging functions for plant MAP kinase phosphatases.
    Bartels S; González Besteiro MA; Lang D; Ulm R
    Trends Plant Sci; 2010 Jun; 15(6):322-9. PubMed ID: 20452268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells.
    Franklin CC; Kraft AS
    J Biol Chem; 1997 Jul; 272(27):16917-23. PubMed ID: 9202001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling.
    Wu JJ; Bennett AM
    J Biol Chem; 2005 Apr; 280(16):16461-6. PubMed ID: 15722358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-translational regulation of mitogen-activated protein kinase phosphatase-2 (MKP-2) by ERK.
    Peng DJ; Zhou JY; Wu GS
    Cell Cycle; 2010 Dec; 9(23):4650-5. PubMed ID: 21084841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.